Development of Novel Multimodal Dextran-Based Theranostic Tracers: Targeting Fibroblast Activation Protein as Proof of Concept

Project Information

POLYTROP

Grant agreement ID: 101130787

DOI

10.3030/101130787

Project closed

EC signature date 11 May 2023

Start date 1 June 2023

End date 31 May 2025

Funded under

• Widening participation and spreading excellence

Total cost

No data

EU contribution

€ 169 326,72

Coordinated by

"NATIONAL CENTER FOR SCIENTIFIC RESEARCH ""DEMOKRITOS"""
Greece

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Data Management Plan (1)

Data Management Plan

The Data Management Plan describes the data management life cyclefor all data sets that will be collected, processed or generated by the action. It is adocument describing what data will be collected, processed or generated andfollowing what methodology and standards, whether and how this data will beshared and/or made open, and how it will be curated and preserved.

Documents, reports (1)

Communication, Dissemination & Exploitation Plan

The plan describes the planned measures to maximize the impact ofthe project, including the dissemination and exploitation measures that are planned,and the target group(s) addressed. Regarding communication measures and publicengagement strategy, the aim is to inform and reach out to society and show theactivities performed, and the use and the benefits the project will have for citizens.

Publications

Peer reviewed articles (4)

Mixed ligand Re and 99mTc tricarbonyl complexes bearing two important pharmacophores: 2-(4′-aminophenyl)benzothiazole and curcumin

Author(s): Alexandros Stouraitis, Marina Sagnou, Barbara Mavroidi, Christos Kiritsis, Antonio Shegani, Catherine Raptopoulou, Vassilis Psycharis, Constantinos Methenitis, Ioannis Pirmettis, Minas Papadopoulos, Maria Pelecanou
Published in: Inorganica Chimica Acta, Issue 571, 2024, ISSN 0020-1693
Publisher: Elsevier BV
DOI: 10.1016/J.ICA.2024.122172

Synthesis and Biological Evaluation of Novel Cationic Rhenium and Technetium-99m Complexes Bearing Quinazoline Derivative for Epidermal Growth Factor Receptor Targeting

Author(s): Sotiria Triantopoulou, Ioanna Roupa, Antonio Shegani, Nektarios N. Pirmettis, Georgia I. Terzoudi, Aristeidis Chiotellis, Maria Tolia, John Damilakis, Ioannis Pirmettis, Maria Paravatou-Petsota
Published in: Pharmaceutics, Issue 16, 2024, ISSN 1999-4923
Publisher: MDPI AG
DOI: 10.3390/PHARMACEUTICS16091213

Pharmaceutics

Author(s): A. Papasavva, N. N. Pirmettis, A. Shegani, E. Papadopoulou, C. Kiritsis, M. Georgoutsou-Spyridonos, D. C. Mastellos, A. Chiotellis, P. Kyprianidou, M. Pelecanou, M. Papadopoulos, I. Pirmettis
Published in: Pharmaceutics, 2024, ISSN 1999-4923
Publisher: MDPI
DOI: 10.3390/PHARMACEUTICS16091210

Synthesis and characterization of rhenium and Technetium-99 m tricarbonyl and dicarbonyl complexes with quinaldic acid and Arsenic/Phosphorus derivatives

Author(s): Charalampos Triantis, Antonio Shegani, Aristeidis Chiotellis, Catherine Raptopoulou, Vassilis Psycharis, Maria Pelecanou, Ioannis Pirmettis, Minas Papadopoulos
Published in: Polyhedron, Issue 264, 2024, ISSN 0277-5387
Publisher: Elsevier BV
DOI: 10.1016/J.POLY.2024.117236